Corpus Intelligence IC Memo — CONWAY HOSPITAL 2026-04-26 06:40 UTC
IC Memo — CONWAY HOSPITAL
Investment Committee Memorandum | SC | 171 beds | Grade C | EBITDA uplift $18.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CONWAY HOSPITAL

CCN 420049 | HORRY, SC | 171 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CONWAY HOSPITAL is a 171-bed suburban community hospital in HORRY, SC with $250.2M in net patient revenue and a -14.7% operating margin. The hospital serves a payer mix of 28.3% Medicare, 7.0% Medicaid, and 64.7% commercial.

Thesis: Undervalued. Our ML models identify $18.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -14.7% to -7.3% (+736bps).

Net Revenue HCRIS$250.2M
Current EBITDA COMPUTED$-36.7M
Operating Margin COMPUTED-14.7%
Occupancy HCRIS58.2%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS25.5%
Distress Probability ML46.3%

2. Market Context & Competitive Position

85
SC Hospitals
1.3%
State Median Margin
27
Comparable Hospitals

SC has 85 Medicare-certified hospitals with a median operating margin of 1.3%. The target's margin of -14.7% places it below the state median. Among 27 size-comparable peers (86-342 beds), the median margin is 0.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (86-342), prioritizing same-state peers. 27 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CONWAY HOSPITAL (Target)SC171$250.2M-14.7%
ST. FRANCIS HOSPITAL INCSC327$691.4M4.9%
GRAND STRAND REGIONAL MEDICAL SC336$602.2M32.8%
SELF REGIONAL HEALTHCARESC290$410.1M4.7%
ROPER HOSPITAL INC.SC266$400.8M-3.0%
BON SECOURS ST. FRANCIS XAVIERSC186$304.6M12.2%
PRISMA HEALTH BAPTIST HOSPITALSC246$277.5M0.4%
BEAUFORT MEMORIAL HOSPITALSC167$269.0M-7.3%
MCLEOD LORIS SEACOAST HOSPITALSC155$262.3M10.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $18.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.3M+210bp18mo
Cost to Collect4.5%2.5%$5.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.0M+122bp9mo
Clean Claim Rate88.0%96.0%$160K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.3M
Cost to Collect
$5.0M
Denial Rate Reduction
$5.0M
A/R Days Reduction
$3.0M
Clean Claim Rate
$160K
Total EBITDA Uplift$18.4M
Current EBITDA$-36.7M
+ RCM Uplift+$18.4M
Pro Forma EBITDA$-18.3M
Current Margin-14.7%
Pro Forma Margin-7.3%
WC Released (1x)$9.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-56.4M$-57.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-56.4M$-81.9M0.00x-100.0%
Bull Case9.0x11.0x$-50.8M$-39.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-50.8M$-58.1M0.00x-100.0%
Bear Case11.0x10.0x$-62.1M$-131.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-62.1M$-164.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 27 hospitals with 86-342 beds
  • Same-state prioritization (n=28)
  • Comp margins: P25=-7.3% / P50=0.2% / P75=9.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.